07.22.10
Sabinsa Corporation, East Windsor, NJ, has received a Grant of Patent from the New Zealand Patent Office, which describes processes to prepare derivatives of forskolin, namely, isoforskolin and 7-deacetylforskolin. NZ Patent No. 568652 “Commercial Process for Making Forskolin and its Derivatives,” will be in force until February 2, 2027.